[go: up one dir, main page]

HK1024184A1 - Ziprasidone formulations - Google Patents

Ziprasidone formulations Download PDF

Info

Publication number
HK1024184A1
HK1024184A1 HK00103630A HK00103630A HK1024184A1 HK 1024184 A1 HK1024184 A1 HK 1024184A1 HK 00103630 A HK00103630 A HK 00103630A HK 00103630 A HK00103630 A HK 00103630A HK 1024184 A1 HK1024184 A1 HK 1024184A1
Authority
HK
Hong Kong
Prior art keywords
particle size
composition
ziprasidone
average particle
less
Prior art date
Application number
HK00103630A
Other languages
English (en)
Chinese (zh)
Other versions
HK1024184B (en
Inventor
F‧R‧布什
A‧C‧G‧哈斯伯格
B‧拉萨迪
D‧R‧阿伦逊
Original Assignee
辉瑞产品公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22216447&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1024184(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 辉瑞产品公司 filed Critical 辉瑞产品公司
Publication of HK1024184A1 publication Critical patent/HK1024184A1/xx
Publication of HK1024184B publication Critical patent/HK1024184B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Polyamides (AREA)
  • Feeding Of Articles By Means Other Than Belts Or Rollers (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HK00103630.0A 1998-06-15 2000-06-16 Ziprasidone formulations HK1024184B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8922998P 1998-06-15 1998-06-15
US089229 1998-06-15

Publications (2)

Publication Number Publication Date
HK1024184A1 true HK1024184A1 (en) 2000-10-05
HK1024184B HK1024184B (en) 2007-09-07

Family

ID=

Also Published As

Publication number Publication date
SG77243A1 (en) 2000-12-19
IS2182B (is) 2006-12-15
JP3441676B2 (ja) 2003-09-02
PL195606B1 (pl) 2007-10-31
BG103489A (en) 2000-07-31
EA002223B1 (ru) 2002-02-28
DK0965343T3 (da) 2003-08-04
HUP9901960A2 (hu) 2000-08-28
CZ212799A3 (cs) 2000-09-13
AU753820B2 (en) 2002-10-31
IS5079A (is) 1999-12-16
BG64691B1 (bg) 2005-12-30
HU226487B1 (en) 2009-03-02
PL333737A1 (en) 1999-12-20
PT965343E (pt) 2003-08-29
AU3398399A (en) 1999-12-23
ZA993938B (en) 2000-12-14
ATE240732T1 (de) 2003-06-15
CY2003002I1 (el) 2009-11-04
SK286245B6 (sk) 2008-06-06
HN1999000089A (es) 1999-11-03
EP0965343A2 (en) 1999-12-22
BR9902268A (pt) 2000-05-02
KR20000006143A (ko) 2000-01-25
NZ336271A (en) 2000-10-27
AR015553A1 (es) 2001-05-02
KR100338915B1 (ko) 2002-05-30
TW590774B (en) 2004-06-11
AP9901579A0 (en) 1999-06-30
OA11064A (en) 2002-03-13
CO5070579A1 (es) 2001-08-28
IL130424A (en) 2003-10-31
ID23546A (id) 2000-05-04
JP4187423B2 (ja) 2008-11-26
EP0965343B1 (en) 2003-05-21
CZ297954B6 (cs) 2007-05-09
PE20000632A1 (es) 2000-07-26
HRP990193A2 (en) 2000-02-29
NO992892L (no) 1999-12-16
IL130424A0 (en) 2000-06-01
EP0965343A3 (en) 2000-02-23
NO992892D0 (no) 1999-06-14
EA199900467A2 (ru) 1999-12-29
JP2002003492A (ja) 2002-01-09
UA59383C2 (uk) 2003-09-15
RS49611B (sr) 2007-06-04
CA2274338A1 (en) 1999-12-15
PL195209B1 (pl) 2007-08-31
HUP9901960A3 (en) 2000-09-28
CN1242987A (zh) 2000-02-02
AP1216A (en) 2003-10-19
HRP990193B1 (en) 2003-08-31
MY121397A (en) 2006-01-28
YU27199A (sh) 2002-12-10
GT199900080A (es) 2000-11-29
UY25649A1 (es) 2000-02-23
TR199901379A2 (xx) 2000-01-21
EA199900467A3 (ru) 2000-04-24
SK76999A3 (en) 2000-12-11
DE69908021T2 (de) 2003-11-27
ES2197581T3 (es) 2004-01-01
US6150366A (en) 2000-11-21
MA26647A1 (fr) 2004-12-20
JP2000007566A (ja) 2000-01-11
CA2274338C (en) 2003-04-15
CN1307994C (zh) 2007-04-04
PA8475601A1 (es) 2000-09-29
DE69908021D1 (de) 2003-06-26
NO316713B1 (no) 2004-04-13
SI0965343T1 (en) 2003-10-31
HU9901960D0 (en) 1999-08-30

Similar Documents

Publication Publication Date Title
JP4187423B2 (ja) ジプラシドン組成物
US20200375968A1 (en) Apixaban formulations
JP2020186190A (ja) イストラデフィリン製剤
US20210401748A1 (en) Powder for oral suspension containing lamotrigine
HK1024184B (en) Ziprasidone formulations
AU2017228681B2 (en) Apixaban formulations
MXPA99005524A (en) Ziprasid formulations
WO2012097867A1 (en) Cladribine particles and pharmaceutical compositions comprising them

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130614

ARF Application filed for restoration

Effective date: 20141111

ARG Restoration of standard patent granted

Effective date: 20150226

PE Patent expired

Effective date: 20190613